INCY · Q2 FY25 · Apr 1 – Jun 30, 2025
Incyte Q2 FY25: where the revenue came from and where it went
Incyte Q2 FY25: revenue $1.2B (+16% year over year). Net profit $0.4B. Largest cohort JAKAFI $0.8B. The whole income statement as a sankey diagram from the SEC filing.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Jul 29, 2025
Tap the diagram to enlarge · figures in billions of dollars
Revenue$1.2B
+16% year over year
Gross profit$1.1B
94% margin
Operating profit$0.5B
44% margin
Net profit$0.4B
33% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 1.2 | 100% | +16% |
| JAKAFI | 0.8 | 67% | |
| OPZELURA | 0.2 | 17% | |
| Product royalty revenues | 0.2 | 17% | |
| Cost of revenue | −0.1 | 8% | |
| Gross profit | 1.1 | 94% margin | +1pp |
| Research & development | −0.3 | 41% | −68pp |
| SG&A | −0.3 | 27% | −2pp |
| Operating profit | 0.5 | 44% margin | +89pp |
| Tax | −0.1 | ||
| Net profit | 0.4 | 33% | +76pp |
Older quarters
New results in your inbox
When a big company reports, you get the diagram before anyone has time to comment on it. No spam, one-click unsubscribe.